Literature DB >> 25904773

Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.

Susan Yung1, Sing Leung Lui2, Chris K F Ng1, Andrew Yim1, Maggie K M Ma3, Kin Yee Lo4, Chik Cheung Chow5, Kwok Hong Chu6, Wai Leung Chak7, Man Fai Lam3, Chun Yu Yung8, Terence P S Yip2, Sunny Wong9, Colin S O Tang1, Flora S K Ng10, Tak Mao Chan11.   

Abstract

BACKGROUND: The impact of a low-glucose peritoneal dialysis (PD) regimen on biomarkers of peritoneal inflammation, fibrosis and membrane integrity remains to be investigated.
METHODS: In a randomized, prospective study, 80 incident PD patients received either a low-glucose regimen comprising Physioneal (P), Extraneal (E) and Nutrineal (N) (Baxter Healthcare Corporation, Deerfield, IL, USA) (PEN group), or Dianeal (control group) for 12 months, after which both groups continued with Dianeal dialysis for 6 months. Serum and dialysate levels of vascular endothelial growth factor (VEGF), decorin, hepatocyte growth factor (HGF), interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), hyaluronan (HA), adiponectin, soluble-intracellular adhesion molecule (s-ICAM), vascular cell adhesion molecule-1 (VCAM-1) and P-selectin, and dialysate cancer antigen 125 (CA125), were measured after 12 and 18 months. This paper focuses on results after 12 months, when patients in the PEN group changed to glucose-based PD fluid (PDF).
RESULTS: At the end of 12 months, effluent dialysate levels of CA125, decorin, HGF, IL-6, adiponectin and adhesion molecules were significantly higher in the PEN group compared to controls, but all decreased after patients switched to glucose-based PDF. Macrophage migration inhibitory factor level was lower in the PEN group but increased after changing to glucose-based PDF and was similar to controls at 18 months. Serum adiponectin level was higher in the PEN group at 12 months, but was similar in the 2 groups at 18 months. Body weight, residual renal function, ultrafiltration volume and total Kt/V did not differ between both groups. Dialysate-to-plasma creatinine ratio at 4 h was higher in the PEN group at 12 months and remained so after switching to glucose-based PDF.
CONCLUSION: Changes in the biomarkers suggest that the PEN PD regimen may be associated with better preservation of peritoneal membrane integrity and reduced systemic vascular endothelial injury.
Copyright © 2015 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Amino acid; biocompatibility; icodextrin; pH neutral; peritoneal dialysis; peritoneal inflammation

Mesh:

Substances:

Year:  2015        PMID: 25904773      PMCID: PMC4406310          DOI: 10.3747/pdi.2014.00125

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  39 in total

1.  Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.

Authors:  C G Schalkwijk; N Posthuma; H J ten Brink; P M ter Wee; T Teerlink
Journal:  Perit Dial Int       Date:  1999 Jul-Aug       Impact factor: 1.756

2.  Possible effects of hepatocyte growth factor for the prevention of peritoneal fibrosis.

Authors:  Koki Matsuo; Yasuhiro Maeda; Yoshito Naiki; Toshiaki Matsuoka; Yoshihisa Tamai; Satoru Yonekawa; Mika Sakaguchi; Ichiro Iwamoto; Hirohumi Hasegawa; Kunio Matsumoto; Toshikazu Nakamura; Akihisa Kanamaru
Journal:  Nephron Exp Nephrol       Date:  2005-01-19

3.  Growth factors VEGF and TGF-beta1 in peritoneal dialysis.

Authors:  M M Zweers; D R de Waart; W Smit; D G Struijk; R T Krediet
Journal:  J Lab Clin Med       Date:  1999-08

4.  Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.

Authors:  Hunjoo Ha; Mi Kyung Cha; Hoo Nam Choi; Hi Bahl Lee
Journal:  Perit Dial Int       Date:  2002 Mar-Apr       Impact factor: 1.756

5.  A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.

Authors:  C D Mistry; R Gokal; E Peers
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

6.  Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.

Authors:  Siska Mortier; Dirk Faict; Casper G Schalkwijk; Norbert H Lameire; An S De Vriese
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

7.  Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Authors:  W A Border; N A Noble; T Yamamoto; J R Harper; Y u Yamaguchi; M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

8.  Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans.

Authors:  S Yung; G J Thomas; E Stylianou; J D Williams; G A Coles; M Davies
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

9.  A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.

Authors:  Sing Leung Lui; Susan Yung; Andrew Yim; Kui Man Wong; Kwok Lung Tong; Kin Shing Wong; Chun Sang Li; Tak Cheung Au; Wai Kei Lo; Yiu Wing Ho; Flora Ng; Colin Tang; Tak Mao Chan
Journal:  Am J Kidney Dis       Date:  2012-07-25       Impact factor: 8.860

10.  Hepatocyte growth factor prevents peritoneal fibrosis in an animal model of encapsulating peritoneal sclerosis.

Authors:  Toshiaki Matsuoka; Yasuhiro Maeda; Koki Matsuo; Yoshito Naiki; Yoshihisa Tamai; Mika Sakaguchi; Hirofumi Hasegawa; Masanori Funauchi; Akihisa Kanamaru
Journal:  J Nephrol       Date:  2008 Jan-Feb       Impact factor: 3.902

View more
  10 in total

1.  The solution to better preservation of the peritoneal membrane still lies hidden in the solution.

Authors:  Dirk G Struijk
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

2.  Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model.

Authors:  Haruhito Yoshimine; Shiroh Tanoue; Yutaro Ibi; Masato Minami; Mai Nakahara; Koki Tokunaga; Shuji Kanmura; Akio Ido
Journal:  Clin Exp Nephrol       Date:  2021-04-28       Impact factor: 2.801

3.  MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor.

Authors:  Xiejia Li; Hong Liu; Lin Sun; Xun Zhou; Xinke Yuan; Yusa Chen; Fuyou Liu; Yu Liu; Li Xiao
Journal:  J Cell Mol Med       Date:  2019-01-28       Impact factor: 5.310

Review 4.  Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress.

Authors:  Stefanos Roumeliotis; Evangelia Dounousi; Marios Salmas; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Biomolecules       Date:  2020-05-14

5.  The estimation of protein equivalents of total nitrogen in Chinese CAPD patients: an explanatory study.

Authors:  Chunyan Su; Tao Wang; Peiyu Wang; Xinhong Lu; Wen Tang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

6.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26

Review 7.  Regulation of synthesis and roles of hyaluronan in peritoneal dialysis.

Authors:  Timothy Bowen; Soma Meran; Aled P Williams; Lucy J Newbury; Matthias Sauter; Thomas Sitter
Journal:  Biomed Res Int       Date:  2015-10-13       Impact factor: 3.411

8.  Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis.

Authors:  Caigan Du; Asher A Mendelson; Qiunong Guan; Ghida Dairi; Irina Chafeeva; Gerald da Roza; Jayachandran N Kizhakkedathu
Journal:  J Transl Med       Date:  2016-12-13       Impact factor: 5.531

9.  Anti-fibrotic effect of decorin in peritoneal dialysis and PD-associated peritonitis.

Authors:  Na Jiang; Qing Zhang; Mel Km Chau; Ming S Yip; Sing Leung Lui; Stephanie Liu; Kent Man Chu; Hextan Ys Ngan; Tak Mao Chan; Susan Yung
Journal:  EBioMedicine       Date:  2020-02-12       Impact factor: 8.143

10.  Biological Effects of XyloCore, a Glucose Sparing PD Solution, on Mesothelial Cells: Focus on Mesothelial-Mesenchymal Transition, Inflammation and Angiogenesis.

Authors:  Valentina Masola; Mario Bonomini; Maurizio Onisto; Pietro Manuel Ferraro; Arduino Arduini; Giovanni Gambaro
Journal:  Nutrients       Date:  2021-06-30       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.